Decadron and Ellence drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Decadron (dexamethasone) and Ellence (epirubicin hydrochloride). Common drug interactions include tooth abscess among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Decadron and Ellence. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.

What is Ellence?

Ellence has active ingredients of epirubicin hydrochloride. eHealthMe is studying from 943 Ellence users. Check the latest studies of Ellence.

On Jul, 13, 2026

58 people who take Decadron and Ellence together, and have interactions are studied.

What are the common drug interactions of Decadron and Ellence, by gender? *:

female:

Tooth abscess (pus formation in tooth)
Vaginal candidiasis (vaginal fungal infection)
Abasia (inability to walk)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Angiopathy (generic term for a disease of the blood vessels)
Anxiety
Aortic atherosclerosis (degenerative process of aortic arteries)
Back pain
Bacteria stool identified
Blood amylase increased

male:

Haemoglobin decreased
Pneumonia
Interstitial lung disease
Malaise (a feeling of general discomfort or uneasiness)
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Platelet count decreased
Respiratory failure (inadequate gas exchange by the respiratory system)
Sensation of pressure
Vomiting
White blood cell count decreased

What are the common drug interactions of Decadron and Ellence, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Nausea (feeling of having an urge to vomit)
Vomiting
Alopecia (absence of hair from areas of the body)
Haematocrit decreased
Haemoglobin decreased
Hair colour changes
Hair disorder
Platelet count increased
Pyrexia (fever)
Syncope (loss of consciousness with an inability to maintain postural tone)

40-49:

Alopecia (absence of hair from areas of the body)
Nausea (feeling of having an urge to vomit)
Vomiting
Abasia (inability to walk)
Angiopathy (generic term for a disease of the blood vessels)
Back pain
Blood amylase increased
Breast pain
Burning sensation
Catheter site related reaction

50-59:

Chest pain
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Electrocardiogram st segment depression
Hair disorder
Hyperhidrosis (abnormally increased sweating)
Mitral valve incompetence (inefficient heart valve)
Neutropenia (an abnormally low number of neutrophils)
Pain
Pco2 decreased

60+:

Alopecia (absence of hair from areas of the body)
Haemoglobin decreased
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Vomiting
White blood cell count decreased
Erythema (redness of the skin)
Nausea (feeling of having an urge to vomit)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Bone disorder

What are the existing conditions these people have? *

Breast Cancer Female: 19 people, 32.76%
Breast Cancer: 18 people, 31.03%
Pain: 3 people, 5.17%

* Approximation only. Some reports may have incomplete information.

Do you take Decadron and Ellence?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously